Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
Patientory Breaks Up [PTOYBTC](150%+ PP)
Patientory / Bitcoin
Patientory Breaks Up [PTOYBTC](150%+ PP)
By AlanSantana
Follow
Follow
Jan 18, 2019
1
1
Jan 18, 2019
Patientory (PTOYBTC) is looking good. Yesterday's candle had the highest volume in a while, this one can move soon.
Quick chart analysis:
We have a high volume breakout above EMA10 and 50 with a bullish MACD and RSI.
Huge volume bar.
Target, stop loss and details on the main chart.
TAKE CARE OF YOUR BODY
Our body is our home, we have to take care of it in every best possible way we can, always.
Eat the right foods.
Drink plenty of water.
Fast every now and then.
Exercise.
Laughter.
Meditation.
Supplements.
Nature.
Love!
Namaste.
alanmasters
binance
bitfinex
bittrex
Chart Patterns
Gann
hitbtc
patientory
poloniex
ptoy
PTOYBTC
Trend Analysis
AlanSantana
Follow
🔥 PREMIUM Trade-Numbers (6-In-1 Offer Live!)
lamatrades.com
(Since 2017)
🔝 Daily Cryptocurrency Technical Analysis
followalan.com
🚨 Free PREMIUM Trade-Numbers
alansantanatrades.com
Also on:
Related publications
Cardano Retrace Completed - Reading The Signals (Learning)
by AlanSantana
PowerLedger Takes Off [POWRBTC](450% PP)
by AlanSantana
Walton (WTCBTC) Targets (Where To Sell 4 Profits)
by AlanSantana
[ETHUSD][LONG][10X][59% ROE] Ethereum Short Term (1H) on BitMEX
by AlanSantana
GoChain Can Make A Solid Move (55%+ Profits Potential)
by AlanSantana
Bread Starts To BreakUp Silently [BRDBTC](83% PP)
by AlanSantana
Monetha About To Move (Up To 740% Profits Potential)
by AlanSantana
Bitcoin (XBT) LONG - 25X Possible (Let's Trade!)
by AlanSantana
BTC Imminent Breakout + 3 Possibles Scenarios + $1,100 Next?
by AlanSantana
Internet of Services Falling Wedge [IOSTBTC](158% PP)
by AlanSantana
Litecoin Retrace Complete? (Looking For Support)
by AlanSantana
UpToken Does 220% In A Matter Of Days
by AlanSantana
EOS Can Be Our Next Winner? Bullish Impulse
by AlanSantana
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.